| 1 | In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase. (Bassetto M, Leyssen P, Neyts J, Yerukhimovich MM, Frick DN, Courtney-Smith M, Brancale A) Eur J Med Chem 2017 Jan 05;125:1115-1131 17 Citations |
| 1 | Optimization of potent hepatitis C virus NS3 helicase inhibitors isolated from the yellow dyes thioflavine S and primuline. (Li K, Frankowski KJ, Belon CA, Neuenswander B, Ndjomou J, Hanson AM, Shanahan MA, Schoenen FJ, Blagg BS, Aubé J, Frick DN) J Med Chem 2012 Apr 12;55(7):3319-30 64 Citations |
| 1 | PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication. (Lam AM, Murakami E, Espiritu C, Steuer HM, Niu C, Keilman M, Bao H, Zennou V, Bourne N, Julander JG, Morrey JD, Smee DF, Frick DN, Heck JA, Wang P, Nagarathnam D, Ross BS, Sofia MJ, Otto MJ, Furman PA) Antimicrob Agents Chemother 2010 Aug;54(8):3187-96 128 Citations |
| 1 | Hepatitis C virus subgenomic replicon requires an active NS3 RNA helicase. (Lam AM, Frick DN) J Virol 2006 Jan;80(1):404-11 111 Citations |
| 1 | Construction and characterization of a highly efficient Francisella shuttle plasmid. (Maier TM, Havig A, Casey M, Nano FE, Frank DW, Zahrt TC) Appl Environ Microbiol 2004 Dec;70(12):7511-9 136 Citations |
